About ARCH Development Partners
ARCH Development Partners is a venture capital firm founded in 2001. It is primarily based out of Chicago Heights, United States. As of Sep 2005, ARCH Development Partners has invested in 10 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and Life Sciences. Most recently it participated in the $***** Series A round of Akoya Overall, ARCH Development Partners portfolio has seen 5 acquisitions including key companies like Rubicon Genomics, Arryx and Akoya. A lot of funds co-invest with ARCH Development Partners, with names like Cat sharing a substantial percentage of its portfolio. ARCH Development Partners has team of 2 people including 1 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A
Portfolio Acquisitions
Portfolio Soonicorns
ARCH Development Partners' List of Top Investments
ARCH Development Partners has a portfolio of 10 companies. Their most notable investments are in ZuChem and ZuChem.Their portfolio spans across and United States. They have invested in Enterprise Applications, High Tech, Life Sciences and 8 other sectors, across stages such as Series A stage. Here is the list of top investments by ARCH Development Partners:1. Adeptia
Cloud based data integration platform for enterprises. It leverages AI that enables users to create a cloud to cloud business integrations using data exchange and mapping, data transformation, and data integration with customers, partners, and suppliers. Features include monitoring data performance, dashboard analytics, information templates, a centralized message center, data protocols, and more.
Key facts about Adeptia
- Founded Year: 2000
- Location: Chicago (United States)
- Annual Revenue: ₹10 - ₹50 Cr as on Mar 31, 2025
- Stage: Series C
- Total Funding till date: $65M
- Employee Count: 187 as on May 31, 2025
- Investors: PSG and ARCH Development Partners
- Latest Funding Round: Series C, Mar 22, 2023, $*****
- Highlight: Editors' Pick
2. ZuChem
Platform offering carbohydrates using bioprocesses. The company develops proprietary bioprocesses for the manufacture of carbohydrates for human health and nutrition. It uses bioprocess and chemical technologies to produce carbohydrates.
Key facts about ZuChem
- Founded Year: 2001
- Location: United States
- Stage: Series A
- Total Funding till date: $1.68M
- Employee Count: 11 as on May 31, 2026
- Investors: Springboard Enterprises, ARCH Development Partners and 5 Others
- Latest Funding Round: Series A, Oct 25, 2016, $*****
Provider of reagents and kits for pre-analytical amplification technologies. The company has three reagent kits to use with Illumina NGS systems and two kits to use with microarray and PCR systems.
Key facts about Rubicon Genomics
- Founded Year: 2000
- Location: Ann Arbor (United States)
- Stage: Acquired
- Total Funding till date: $13M
- Employee Count: 4 as on May 31, 2026
- Investors: ARCH Development Partners, RCT and 1 Other
- Latest Funding Round: Series B, Jul 15, 2015, $*****
- Highlight: Acquired
4. Arryx
Key facts about Arryx
- Founded Year: 2000
- Location: Chicago (United States)
- Stage: Acquired
- Employee Count: 30 as on May 31, 2026
- Investors: ARCH Development Partners and Ojp
- Latest Funding Round: Grant (prize money), Sep 12, 2011, $*****
- Highlight: Acquired
5. Akoya
Diverse enterprise specializing in commercial pipe bursting and related services. The company focuses on kitchen remodeling, pipe cleaning, and reinstating. Additional services include stack inspection to prevent operational halts and drain cleaning to avoid plumbing malfunctions and odors. They offer preventive solutions for home owners and businesses, ensuring functional order and avoiding costly repairs. The company is involved in multiple activities, providing a range of services related to home improvement and infrastructure maintenance. They are not a tech company, SaaS, Software, Cloud Based, cart, login, book now, subsciprtion, pricing, Blockchain, or Artifical Intellignece company.
Key facts about Akoya
- Founded Year: 1994
- Location: Illinois City (United States)
- Stage: Acquired
- Total Funding till date: $2.3M
- Employee Count: 5 as on Jul 01, 2024
- Investors: Village Ventures, ARCH Development Partners and 3 Others
- Latest Funding Round: Series A, Sep 06, 2005, $*****
- Highlight: Acquired
ARCH Development Partners' Investments by Stage
ARCH Development Partners has made 3 investments in Series A stage with an average round size of $4.57M.ARCH Development Partners' Investments by Sector
ARCH Development Partners has a diverse portfolio, with companies operating in the Food and Agriculture Tech, High Tech and Sustainability Tech. Notably, it has invested in 6 Enterprise (B2B) companies, 6 Tech companies, 3 Software companies and at least 2 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Food and Agriculture Tech | 1 |
High Tech | 1 |
Sustainability Tech | 1 |
Note: We have considered here, only first round of investments
ARCH Development Partners' Investments by Geography
ARCH Development Partners has made most investments in United States (3).ARCH Development Partners' recent investments
ARCH Development Partners has not made any investment in 2026 so far.Here are the most recent investments by ARCH Development Partners:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Sep 06, 2005 | United States | Series A | 2749 | [+3] | |
Nov 08, 2004 | United States | Series A | 4545 | ||
Apr 13, 2004 | United States | Series A | 2334 | ||
Apr 2003 | United States | Series A | 9587 | - | |
Jan 02, 2002 | United States | Series A | 9708 | [+2] |
Acquired companies in ARCH Development Partners' Portfolio
5 companies from ARCH Development Partners' portfolio have been acquired. The most recent acquisition was Rubicon Genomics in Dec 2016 by Takara Bio for $*****.Here are ARCH Development Partners' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 15, 2016 | - | - | 5103 | |
Jun 29, 2015 | - | - | 6262 | |
Mar 27, 2014 | Nov 08, 2004 | Series A | 1981 | |
Jan 06, 2011 | Jan 02, 2002 | Series A | 1354 | |
Jun 08, 2006 | - | - | 6235 |
Team profile of ARCH Development Partners
ARCH Development Partners has a team of 2 members located in United States. ARCH Development Partners' team does not sit on the board of any company as of now.Co-investors of ARCH Development Partners
Over the past 24 years, 11 investors have co-invested in ARCH Development Partners's portfolio companies. This includes only funds.
- Top Co-investors of ARCH Development Partners: 4 investors entered a company along with ARCH Development Partners. These include investors like Cat (1 company).
- Invested after ARCH Development Partners: A total of 7 investors have invested in ARCH Development Partners's portfolio after their investments. Top Investors include Biotechnology Research and Development Corporation (1 company), OSTI (1 company) and National Science Foundation (1 company).
